Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
High Insider Ownership ASX Growth Companies To Watch In June 2024

In This Article:

As the Australian market navigates through a diverse range of sector performances and economic signals, with the ASX200 showing resilience in its upward movement, investors continue to seek solid opportunities amidst these fluctuations. High insider ownership can be a reassuring signal for potential stability and growth in companies, particularly valuable in current market conditions where strategic insights from insiders could steer companies effectively through uncertain economic waters.

Top 10 Growth Companies With High Insider Ownership In Australia

Name

Insider Ownership

Earnings Growth

Hartshead Resources (ASX:HHR)

13.9%

86.3%

Cettire (ASX:CTT)

28.7%

26.7%

Acrux (ASX:ACR)

14.6%

115.3%

Plenti Group (ASX:PLT)

12.8%

106.4%

Hillgrove Resources (ASX:HGO)

10.4%

45.4%

Change Financial (ASX:CCA)

26.6%

76.4%

Biome Australia (ASX:BIO)

34.9%

114.4%

Botanix Pharmaceuticals (ASX:BOT)

11.4%

120.9%

Liontown Resources (ASX:LTR)

16.4%

62.3%

Argosy Minerals (ASX:AGY)

14.5%

129.6%

Click here to see the full list of 90 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

Botanix Pharmaceuticals

Simply Wall St Growth Rating: ★★★★★★

Overview: Botanix Pharmaceuticals Limited, based in Australia, focuses on the research and development of dermatology and antimicrobial products with a market capitalization of A$574.93 million.

Operations: The company generates revenue primarily through its research and development activities in dermatology and antimicrobial products, totaling A$0.44 million.

Insider Ownership: 11.4%

Botanix Pharmaceuticals, with its expected annual revenue growth of 120.4%, is poised to outpace the Australian market significantly. Despite making less than A$1 million in revenue, the company's earnings are projected to grow by 120.89% annually. Recently, Botanix filed for a follow-on equity offering of A$70 million to support its commercial launch plans for SofdraÔ as it nears approval. However, shareholders have experienced dilution over the past year, and the firm has less than one year of cash runway remaining.

ASX:BOT Ownership Breakdown as at Jun 2024
ASX:BOT Ownership Breakdown as at Jun 2024

Flight Centre Travel Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Flight Centre Travel Group Limited operates as a travel retailer serving both leisure and corporate sectors across various regions including Australia, New Zealand, the Americas, Europe, the Middle East, Africa, and Asia, with a market capitalization of approximately A$4.41 billion.


Waiting for permission
Allow microphone access to enable voice search

Try again.